echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Diabetes Care: Is your glycation okay?

    Diabetes Care: Is your glycation okay?

    • Last Update: 2021-10-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Early, a United Kingdom Prospective Diabetes Study (UKPDS) showed that intensive glycemic control, compared with conventional glycemic control, HbA1c levels averaged 0.
    9% lower, reducing the micro type 2 diabetes (T2D) patients with vascular risk of complications
    .


    The risk of all-cause death (ACM) and myocardial infarction (MI) did not decrease, although the 16% reduction in MI risk was statistically marginal (P = 0.


    Diabetes and blood sugar control compared to conventional, HbA1c levels averaged 0.


    When cardiovascular HbA1c is reduced by 0.


    At present, the legacy effect is considered to be a bridge between diabetes and its complications, as well as a challenge for blood sugar management


    In order to explore the relationship between the blood glucose legacy effect and the previous HbA1c value, and to explore the potential effects of early hypoglycemic treatment and delayed hypoglycemic treatment, experts from the Institute of Medicine of Sahlgrenska College, University of Gothenburg in Sweden carried out related research, and the results were published in the journal Diabetes Care On
    .

    The researchers started with the T2D diagnosis of 3802 participants in the UK Prospective Diabetes Study (UKPDS 88) and estimated the risk functions of ACM and MI for 20 years
    .


    According to the HbA1c value, the influence of downstream ACM and MI risk is weighted and analyzed


    diagnosis

    The results showed that for every percentage point increase in HbA1c, the risk of ACM at 5, 10, and 20 years increased by 8%, 18%, and 36%, respectively (HR=1.
    08, 95% CI 1.
    07-1.
    09; 1.
    18, 1.
    15-1.
    21; 1.
    36 , 1.
    30-1.
    42); The risk of MI increased by 13% (HR=1.
    13, 1.
    11-1.
    15) in 5 years and 31% in 20 years (HR=1.
    31, 1.
    25-1.
    36)
    .

    The results showed that for every percentage point increase in HbA1c, the risk of ACM at 5, 10, and 20 years increased by 8%, 18%, and 36%, respectively (HR=1.
    08, 95% CI 1.
    07-1.
    09; 1.
    18, 1.
    15-1.
    21; 1.
    36 , 1.
    30-1.
    42); The risk of MI increased by 13% (HR=1.
    13, 1.
    11-1.
    15) in 5 years and 31% in 20 years (HR=1.
    31, 1.
    25-1.
    36)
    .


    The results showed that for every percentage point increase in HbA1c, the risk of ACM at 5, 10, and 20 years increased by 8%, 18%, and 36%, respectively (HR=1.


    Time-dependent HR of death from all causes (left) and myocardial infarction (right) from 0 to 20 years after the diagnosis of type 2 diabetes
    .

    On the other hand, reducing HbA1c by one percentage point from the beginning of diagnosis will reduce the risk of ACM by 18.
    8% (95% CI 21.
    1-16.
    0) after 10-15 years, and postpone this reduction to 10 years after diagnosis, the risk is only 1/7 , Which is 2.
    7% (3.
    1-2.
    3)
    .


    Reducing HbA1c at the time of diagnosis, the corresponding MI risk was reduced by 19.


    On the other hand, reducing HbA1c by one percentage point from the beginning of diagnosis will reduce the risk of ACM by 18.


    In summary, early detection of diabetes and begin intensive glucose control from the time of diagnosis, to maximize the reduction of hypoglycemia long-term risk of complications is essential


    references:

    Historical HbA1c Values ​​May Explain the Type 2 Diabetes Legacy Effect: UKPDS 88.


    Historical HbA1c Values ​​May Explain the Type 2 Diabetes Legacy Effect: UKPDS 88.
    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.